What Is USANA Health Sciences, Inc. (USNA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, USANA Health Sciences, Inc. presents a highly debated valuation profile at its current price of $22.02. The composite intrinsic value is estimated at $21.23 (-3.6% average upside), masking a wide model spread between the 4 bullish models and 7 bearish models. Model dispersion is worth noting: EPV targets $39.79 (+80.7%), versus Regime Cross at $10.37 (-52.9%). This +133.6% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About USNA?
13 of 13 models are currently active for USNA. Of these, 4 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates USNA's intrinsic value at $36.38, implying +65.2% upside from the current price. See which stocks rank higher →
How Does USNA Rank in Medicinal Chemicals & Botanical Products?
Among 17 Medicinal Chemicals & Botanical Products stocks, USNA ranks #3 by Quality of Company score. CirclFi's QOC score of 7.6/10 evaluates 32 fundamental signals. A score of 7.6 indicates above-average quality.
Within the Medicinal Chemicals & Botanical Products space, USANA Health Sciences, Inc. competes in an environment where book-to-bill ratio often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is USNA a Value Trap?
CirclFi's Value Trap algorithm assigns USNA a score of 31/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for USANA Health Sciences, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, USANA Health Sciences, Inc. is rated at 7.6/10. This strong-tier score demonstrates strong fundamentals across the majority of our quality signals.
The gap between the most bullish and bearish model spans +133.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every USNA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across USNA's 13 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad